The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China.
CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Cell Death Differ. 2022 Jun;29(6):1107-1122. doi: 10.1038/s41418-022-01015-x. Epub 2022 May 17.
The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.
新型冠状病毒病 (COVID-19) 已在全球大流行超过 2 年,它以前所未有的方式持续影响着我们的日常生活方式和质量。我们迫切需要更好地了解针对 SARS-CoV-2 感染的免疫及其调节。基于目前的文献,我们在这里回顾了各种病毒突变以及疾病表现的不断演变,同时特别关注固有免疫反应、中性粒细胞胞外陷阱、体液免疫和细胞免疫的变化。根据其引发特定免疫的独特特性,对不同类型的疫苗进行了比较和分析。讨论了各种治疗策略,如抗体、抗病毒药物和炎症控制。我们预测,随着现有和不断涌现的新技术、更强大的疫苗和接种计划、更有效的药物和更好的公共卫生措施,COVID-19 大流行将在不久的将来得到控制。
Cell Death Differ. 2022-6
J Infect Dev Ctries. 2020-9-30
J Biol Regul Homeost Agents. 2021
Arch Immunol Ther Exp (Warsz). 2023-2-21
Vaccines (Basel). 2025-2-27
Int J Mol Sci. 2025-3-13
Front Microbiol. 2022-3-4
Signal Transduct Target Ther. 2022-2-25
Nat Hum Behav. 2022-2
Emerg Microbes Infect. 2022-12